Author Archives: Joline Lim

BIOTECH

EBT Medical and NinaMED Announce US$13.75M Financing to Advance Licensed NiNA System® for Overactive Bladder

US$13.75M financing completed to accelerate clinical pathway and global commercialisation Establishment of NinaMED Pty Ltd,...

Read more

BIOTECH

Hope for Dry AMD: Novel Gene Therapy Completes First Human Safety Trial

Paris, France – April 23, 2026 – In a significant development for the millions suffering...

Read more

DIGITAL CLINICAL SOLUTION

ObvioGo Now Integrated with Oracle Life Sciences Clinical One Data Collection

Collaboration adds critical decentralized trial capabilities to the Oracle Life Sciences Clinical One Data Collection solution NEW...

Read more

BIOTECH

Dosing completed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA)

Paris, France, January 22, 2026 – PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing...

Read more

BIOTECH

ErVimmune raises €17 million in Series A first closing to enter clinical development with lead cancer vaccine candidate

Next-generation therapeutic vaccines company also welcomes industry veteran Eric Halioua to board, as executive chairman....

Read more